Humanized anti-CD20 monoclonal antibody in the treatment of severe resistant systemic lupus erythematosus in a patient with antibodies against rituximab

被引:60
作者
Tahir, H
Rohrer, J
Bhatia, A
Wegener, WA
Isenberg, DA
机构
[1] UCL, Dept Med, Ctr Rheumatol, London W1T 4NJ, England
[2] Immunomed Inc, Morris Plains, NJ USA
关键词
D O I
10.1093/rheumatology/keh533
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:561 / 562
页数:3
相关论文
共 3 条
[1]   An open study of B lymphocyte depletion in systemic lupus erythematosus [J].
Leandro, MJ ;
Edwards, JC ;
Cambridge, G ;
Ehrenstein, MR ;
Isenberg, DA .
ARTHRITIS AND RHEUMATISM, 2002, 46 (10) :2673-2677
[2]  
LEANDRO MJ, 2003, ARTHRITIS RHEUM, V48, pS924
[3]   Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma [J].
Stein, R ;
Qu, ZX ;
Chen, S ;
Rosario, A ;
Shi, V ;
Hayes, M ;
Horak, ID ;
Hansen, HJ ;
Goldenberg, DM .
CLINICAL CANCER RESEARCH, 2004, 10 (08) :2868-2878